Publicaciones en colaboración con investigadores/as de Instituto Canario de Investigación del Cáncer (4)

2023

  1. Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer

    International Journal of Biological Sciences, Vol. 19, Núm. 6, pp. 1731-1747

2017

  1. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

    Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698

2010

  1. Enhancement of antiproliferative activity by molecular simplification of catalpol

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 7, pp. 2515-2523

  2. Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors

    Journal of Medicinal Chemistry, Vol. 53, Núm. 9, pp. 3835-3839